Stryker Corp (SYK)
384.85
-5.29
(-1.36%)
USD |
NYSE |
Nov 22, 16:00
385.01
+0.16
(+0.04%)
Pre-Market: 20:00
Stryker Free Cash Flow: 3.205B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | 3.205B |
June 30, 2024 | 2.803B |
March 31, 2024 | 2.858B |
December 31, 2023 | 3.136B |
September 30, 2023 | 2.568B |
June 30, 2023 | 2.417B |
March 31, 2023 | 2.267B |
December 31, 2022 | 2.036B |
September 30, 2022 | 2.015B |
June 30, 2022 | 2.067B |
March 31, 2022 | 2.453B |
December 31, 2021 | 2.738B |
September 30, 2021 | 3.016B |
June 30, 2021 | 2.973B |
March 31, 2021 | 2.712B |
December 31, 2020 | 2.79B |
September 30, 2020 | 2.254B |
June 30, 2020 | 1.96B |
March 31, 2020 | 1.798B |
December 31, 2019 | 1.542B |
September 30, 2019 | 1.898B |
June 30, 2019 | 1.91B |
March 31, 2019 | 2.053B |
December 31, 2018 | 2.038B |
September 30, 2018 | 1.639B |
Date | Value |
---|---|
June 30, 2018 | 1.098B |
March 31, 2018 | 1.125B |
December 31, 2017 | 961.00M |
September 30, 2017 | 983.00M |
June 30, 2017 | 1.43B |
March 31, 2017 | 1.29B |
December 31, 2016 | 1.425B |
September 30, 2016 | 1.584B |
June 30, 2016 | 614.00M |
March 31, 2016 | 524.00M |
December 31, 2015 | 711.00M |
September 30, 2015 | 655.00M |
June 30, 2015 | 1.717B |
March 31, 2015 | 1.744B |
December 31, 2014 | 1.549B |
September 30, 2014 | 1.547B |
June 30, 2014 | 1.65B |
March 31, 2014 | 1.643B |
December 31, 2013 | 1.691B |
September 30, 2013 | 1.622B |
June 30, 2013 | 1.554B |
March 31, 2013 | 1.651B |
December 31, 2012 | 1.447B |
September 30, 2012 | 1.463B |
June 30, 2012 | 1.341B |
Free Cash Flow Range, Past 5 Years
1.542B
Minimum
Dec 2019
3.205B
Maximum
Sep 2024
2.480B
Average
2.510B
Median
Free Cash Flow Benchmarks
Boston Scientific Corp | 1.892B |
Globus Medical Inc | 293.77M |
Zimmer Biomet Holdings Inc | 1.259B |
Baxter International Inc | 391.00M |
Treace Medical Concepts Inc | -43.20M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 1.474B |
Cash from Investing (Quarterly) | -2.172B |
Cash from Financing (Quarterly) | 2.653B |
Free Cash Flow Per Share (Quarterly) | 3.382 |
Free Cash Flow to Equity (Quarterly) | -1.958B |
Free Cash Flow to Firm (Quarterly) | 1.304B |
Free Cash Flow Yield | 2.16% |